Status:
COMPLETED
Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension
Lead Sponsor:
Rehman Medical Institute - RMI
Conditions:
Hypotension
Anesthesia
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Background: Spinal anesthesia (SA) is preferred over general anesthesia in Cesarean section (CS) due to its better safety profile but SA induced hypotension remains a big challenge for the clinical An...
Detailed Description
Introduction: World Health Organization (WHO) defines maternal death as a death while pregnant or within 42 days of the end of gestation, from any cause related to or aggravated by the pregnancy or it...
Eligibility Criteria
Inclusion
- All pregnant ladies of American Society of Anesthesiologists (ASA) physical status 1 or 2 with
- Singleton Pregnancy,
- Full term pregnancy, and
- Admitted for elective CS
Exclusion
- All those participants having;
- Blood pressure ≥140/90 mm of Hg,
- ASA 3 or above status,
- Contraindication to spinal anesthesia
- Fetal anomalies/
- Abnormal placentae
- Refusal to consent
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05348980
Start Date
January 1 2020
End Date
July 31 2020
Last Update
April 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehman Medical Institute
Peshawar, Khyber Pakhtunkhwa, Pakistan, 25000